Escalation with Overdose Control Using Ordinal Toxicity Grades for Cancer Phase I Clinical Trials
Figure 3
Summary statistics for trial safety for EWOC and EWOC-POM under all scenarios. Each graph represents mean proportion obtained from all patients from all 1000 simulated trials.
